IPO. But the performance of past IPOs is souring, raising questions about investor enthusiasm for big deals. Read more ...
US IPOs emerged out of a tumultuous April with strong price momentum going into the summer. Click here to read more about 2025 US IPOs and their performance.
When Bitcoin starts moving, do investors wait, or do they hunt for the next early entry? Many market watchers do both. They ...
AI and deeptech advancements are transforming healthcare infrastructure, delivering novel approaches to safer, more efficient and more personalised patient careAdvancing innovation within the ...
Feb 12 (Reuters) - PayPay publicly filed its paperwork for a U.S. initial public offering on Thursday, as the SoftBank-backed Japanese payments app moves ahead with its highly anticipated stock ...
As global AI power consolidates, India advances an inclusive governance model that bridges divides, promotes fair competition ...
The National Stock Exchange (NSE) board plans to initiate its IPO process on February 6 following regulatory approval from SEBI. Expected to form an IPO committee, the board will outline listing ...
Russian President Vladimir Putin has instructed the Central Bank and the government to develop and implement an IPO and SPO (primary and secondary placement of shares) program for state-owned ...
A six-state pilot program will target 'wasteful care' under Medicare Medicare programs in six states will face prior authorizations under a new pilot program. Traditional Medicare in six states will ...
India’s equity capital markets have experienced a significant transformation between 2020 and 2025, shifting from being a cyclical fund-raising avenue to a structurally deeper and more resilient ...
Florida Gov. Ron DeSantis has recently taken stances that differ from former President Donald Trump on several key issues. DeSantis and Trump have conflicting views on state versus federal regulation ...
Hosted on MSN
Nasus Pharma highlights transformational 2025 as NS002 intranasal epinephrine program advances and IPO completes
An announcement from Nasus Pharma Ltd. ( (NSRX)) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from CEO Dan Teleman highlighting a transformational year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results